Spain – Pharmaceutical products – SUMINISTRO DE LOS MEDICAMENTOS EXCLUSIVOS JAKAVI (PRINCIPIO ACTIVO RUXOLITINIB), REVOL
SERVICIO RIOJANO DE SALUD awarded €785K to NOVARTIS FARMACÉUTICA S.A. for Construction & Public Works in January 2025 — one of 439 awards this buyer has made, above its typical award size.
Buying agency
SERVICIO RIOJANO DE SALUDWinning supplier
NOVARTIS FARMACÉUTICA S.A.Contract description
Spain – Pharmaceutical products – SUMINISTRO DE LOS MEDICAMENTOS EXCLUSIVOS JAKAVI (PRINCIPIO ACTIVO RUXOLITINIB), REVOLADE (PRINCIPIO ACTIVO ELTROMBOPAG) Y CONSENTYX (PRINCIPIO ACTIVO SECUKINUMAB) CON DESTINO A LOS SERVICIOS DE FARMACIA DEL SERVICIO RIOJANO DE SALUD
Related awards · SERVICIO RIOJANO DE SALUD
439 awardsThe buyer's full award list ranked by value, with the winning supplier, date and sector on every row — plus CSV / API export.
- ocds-ted-284173-2025-1ISS FACILITY SERVICES SA€8.6M02 May 2025 Professional Services
- ocds-ted-670775-2024ELIS MANOMATIC S.A.U€8.3M05 Nov 2024 Professional Services
- ocds-ted-284173-2025-3HORI-HORI, S.A.€2.8M02 May 2025 Professional Services
Other wins · NOVARTIS FARMACÉUTICA S.A.
177 winsThe supplier's complete win history across every buyer it sells to — not just the handful shown here.
Premium · full dataset
See the full award context.
Competing bids, award margins and every related contract for SERVICIO RIOJANO DE SALUD and NOVARTIS FARMACÉUTICA S.A. — one subscription unlocks everything.
Sign Up Free →Free account · cancel anytime · 14-day money-back